Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 9 | BMC Medicine

Fig. 9

From: Major milestones in translational oncology

Fig. 9

J.P. Michiel Sedelaar. J.P. Michiel Sedelaar is the deputy-chief of the department of Urology at Radboud University Medical Center, Nijmegen, the Netherlands. He finished his urology training in 2007 and in 2008–2009 he was a post-doc researcher at the Johns Hopkins Medical Institutes in Baltimore, MD, USA. His focus during that time was the development of smart-drugs for detection and treatment of prostate cancer and steroidogenesis of prostate cancer. Since 2010, he returned to Nijmegen for an onco-urology staff position. His research achievements are mainly on imaging studies for prostate cancer (use of MRI, MRI-guided treatments) and basic research on the androgen receptor in prostate cancer. He has national and international board functions; among others, he is the chair of the EAU-Young Urology Office

Back to article page